Ftse Mib
33.746,66
-1,60%
DAX
17.932,17
-1,10%
S&P 500
5.018,39
-0,34%
NASDAQ Composite
15.605,48
-0,33%
Bitcoin
57.533,73
-1,21%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Corcept Therapeutics Inc (CORT) Corcept Therapeutics Inc (CORT) Notizie

Corcept Therapeutics Inc

CORT
26,90
3,58 (15,35%)
02 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
01/5/202422:05GLOBECorcept Therapeutics Announces First Quarter Financial..
29/4/202414:00GLOBECorcept Completes Enrollment in Phase 4 CATALYST Trial
24/4/202422:05GLOBECorcept Therapeutics to Announce First Quarter Financial..
22/4/202414:00GLOBECorcept Announces Positive Results From Open-Label Portion..
15/4/202414:00GLOBECorcept Completes Enrollment in Phase 2 DAZALS Trial in..
08/4/202414:00GLOBECorcept Completes Enrollment in Pivotal Phase 3 Rosella..
01/4/202414:00GLOBECorcept Completes Enrollment in Phase 3 Gradient Trial of..
06/3/202403:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202403:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202403:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202403:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202403:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202402:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202423:24EDGAR2Form 144 - Report of proposed sale of securities
22/2/202403:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202402:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202418:12EDGAR2Form 144 - Report of proposed sale of securities
15/2/202422:17EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
15/2/202422:11EDGAR2Form 8-K - Current report
15/2/202422:07GLOBECorcept Therapeutics Announces Fourth Quarter and Full-Year..
15/2/202422:02GLOBECorcept Announces Preliminary Results From Prevalence Phase..
15/2/202421:45EDGAR2Form 144 - Report of proposed sale of securities
14/2/202422:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202402:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202402:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202402:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202402:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202401:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202401:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202401:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202422:46EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
13/2/202401:51EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202422:05GLOBECorcept Therapeutics to Announce Fourth Quarter and..
02/2/202423:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202420:17EDGAR2Form 144 - Report of proposed sale of securities
29/1/202414:00GLOBECorcept Appoints Roberto Vieira as President, Oncology
22/1/202421:52EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/1/202402:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202414:06EDGAR2Form 8-K - Current report
08/1/202414:00GLOBECorcept Therapeutics Provides Financial Update and Announces..
05/1/202401:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202417:24EDGAR2Form 144 - Report of proposed sale of securities
02/1/202414:06EDGAR2Form 8-K - Current report
02/1/202414:00GLOBECourt Finds Corcept Therapeutics’ Patents Not Infringed
23/12/202301:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202318:09EDGAR2Form 144 - Report of proposed sale of securities
20/12/202300:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202303:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202302:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202322:34EDGAR2Form 8-K - Current report
Apertura: 23,09 Min: 22,60 Max: 24,61
Chiusura: 23,32

La tua Cronologia

NASDAQ
CORT
Corcept Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network